Literature DB >> 10891923

Activated microglia in dementia with Lewy bodies.

I R Mackenzie1.   

Abstract

To investigate the role of cerebral inflammation in dementia with Lewy bodies (DLB), activated microglial cells were quantified in postmortem brain tissue. Patients with pure DLB (LB but no AD pathology) had significantly greater numbers of cells than nondemented control subjects, but fewer than patients with either pure AD or DLB combined with AD. There was a positive correlation between the numbers of activated microglia and LB in different brain regions. This study demonstrates the presence of significant inflammation in DLB, even in the absence of AD pathology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891923     DOI: 10.1212/wnl.55.1.132

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 2.  Environmental neurotoxicant-induced dopaminergic neurodegeneration: a potential link to impaired neuroinflammatory mechanisms.

Authors:  Arthi Kanthasamy; Huajun Jin; Adhithiya Charli; Anantharam Vellareddy; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2019-01-22       Impact factor: 12.310

Review 3.  Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia.

Authors:  William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Adv Pharmacol       Date:  2017-11-10

4.  Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein.

Authors:  Arianna Bellucci; Andrew J Westwood; Esther Ingram; Fiorella Casamenti; Michel Goedert; Maria Grazia Spillantini
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

5.  Diffuse Lewy Body Disease.

Authors:  Theresa A. Zesiewicz; Matthew J. Baker; Peter B. Dunne; Robert A. Hauser
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

6.  Changes in CD200 and intercellular adhesion molecule-1 (ICAM-1) levels in brains of Lewy body disorder cases are associated with amounts of Alzheimer's pathology not α-synuclein pathology.

Authors:  Douglas G Walker; Lih-Fen Lue; Tiffany M Tang; Charles H Adler; John N Caviness; Marwan N Sabbagh; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

Review 7.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

8.  CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology.

Authors:  Elizabeth M Bradshaw; Lori B Chibnik; Brendan T Keenan; Linda Ottoboni; Towfique Raj; Anna Tang; Laura L Rosenkrantz; Selina Imboywa; Michelle Lee; Alina Von Korff; Martha C Morris; Denis A Evans; Keith Johnson; Reisa A Sperling; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Nat Neurosci       Date:  2013-05-23       Impact factor: 24.884

9.  Lewy body cortical involvement may not always predict dementia in Parkinson's disease.

Authors:  C Colosimo; A J Hughes; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

Review 10.  Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.

Authors:  Lisa Fellner; Kurt A Jellinger; Gregor K Wenning; Nadia Stefanova
Journal:  Acta Neuropathol       Date:  2011-05-12       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.